BiotechTubeBiotechTube
Home/Editas Medicine/Amy Parison
AP

Amy Parison

Senior Vice President and Chief Financial Officer

Editas Medicine

Therapeutic Areas

CardiovascularHematologyOncology

Editas Medicine Pipeline

DrugIndicationPhase
EDIT-401Hyperlipidemia and Atherosclerotic Cardiovascular Disease (ASCVD)Pre-clinical
Undisclosed In Vivo ProgramSickle Cell Disease (SCD)Research
Alpha-beta T-cell medicinesOncologyUndisclosed
Gamma-delta T-cell medicinesOncologyUndisclosed

Leadership Team at Editas Medicine

GO
Gilmore O’Neill
President and Chief Executive Officer
BB
Brieana Buckley
Senior Vice President, Development and Program Leadership
LC
Linda C. Burkly
Executive Vice President and Chief Scientific Officer
DG
Damien Grierson
Senior Vice President and General Counsel
FP
Frank Panaccio
Senior Vice President and Chief Business Officer
GW
Gregory Whitehead
Executive Vice President and Chief Technical and Quality Officer
View full Editas Medicine profile